Velasco, Febdrick A.

HRN: 21-46-66  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/14/2022
CEFUROXIME 750MG (VIAL)
06/14/2022
06/20/2022
IV DRIP
250mg
Q8
PCAP D
Waiting Final Action 
06/14/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/14/2022
06/20/2022
IVT
110mg
OD
PCAP D
Waiting Final Action 
06/16/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/16/2022
06/22/2022
IV
300mg
Q6
Pneumonia
Waiting Final Action 
06/20/2022
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
06/20/2022
06/26/2022
PO
2ml
BID
PCAP D
Waiting Final Action 
06/21/2022
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
06/21/2022
06/27/2022
ORAL
2.5ml
Q12Hrs
Pneumonia
Waiting Final Action 
06/25/2022
CEFTRIAXONE 1G (VIAL)
06/25/2022
07/01/2022
IVTT
600mg
Q24
PCAP
Waiting Final Action 
06/30/2022
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/30/2022
07/07/2022
IV
1.7grm
Q8h
PCAP C
Waiting Final Action 
07/04/2022
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
07/04/2022
07/10/2022
IV
44mg As LD, Then 22mg IV OD As MD, To Start 24h Af
OD
PCAP D
Waiting Final Action 
07/04/2022
CIPROFLOXACIN 500MG (TAB)
07/04/2022
07/11/2022
PER OGT
73mg Pptab
Q12
PCAP D
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: